SCHEMBL1403427

SCHEMBL1403427

C=CC(=O)OCC[N+](C)(C)C.Cc1ccc(S(=O)(=O)[O-])cc1

nearest known ligand 0.41

Known targets — ChEMBL curated mechanism

CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM1 known ✓ P11229 5/20 0.38
CHRM3 known ✓ P20309 5/20 0.38
CHRM2 known ✓ P08172 4/20 0.38
CHRM4 known ✓ P08173 4/20 0.38
CHRM5 known ✓ P08912 3/20 0.37
THRB P10828 1/20 0.41
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
TSHR P16473 6/20 0.37
HPGD P15428 1/20 0.37
CYP3A4 P08684 2/20 0.37
LMNA P02545 2/20 0.37
CYP2D6 P10635 1/20 0.37
MAPK1 P28482 1/20 0.37
THPO P40225 1/20 0.37
ALDH1A1 P00352 3/20 0.37
TP53 P04637 2/20 0.37
HIF1A Q16665 2/20 0.37
HTR1A P08908 2/20 0.37
CHRNB2 P17787 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28623436 0.92 TSHR (0.42) THRBHTTNPSR1TSHRHPGD
SCHEMBL28419016 0.91 TSHR (0.44) THRBHTTNPSR1TSHRHPGD
SCHEMBL1403432 0.89 CYP1A2 (0.43) THRBHTTCHRM1CHRM3CHRM2
SCHEMBL9146546 0.88 TSHR (0.41) THRBHTTCHRM1CHRM3CHRM2
SCHEMBL22042227 0.85 HTT (0.37) HTTCHRM1CHRM3CHRM2CHRM4
Sulfuric Acid SCHEMBL1952726 0.84 TSHR (0.47) THRBCHRM1CHRM3CHRM2CHRM4
Acetylcholine SCHEMBL14840380 0.83 CHRM1 (0.58) HTTCHRM1CHRM3CHRM2CHRM4
Sulfuric Acid SCHEMBL1952728 0.82 TSHR (0.46) THRBCHRM1CHRM3CHRM2CHRM4
Sulfuric Acid SCHEMBL31228302 0.82 CHRM5 (0.48) THRBCHRM1CHRM3CHRM2CHRM4
SCHEMBL28171146 0.82 TSHR (0.46) THRBCHRM1CHRM3CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3892612-B1 METHOD FOR PRODUCING ORGANIC TELLURIUM COMPOUND AND METHOD FOR PRODUCING VINYL POLYMER OTSUKA CHEMICAL CO LTD (JP) 2025-05-14 EP disclosed
WO-2024116876-A1 BLOCK COPOLYMER, DISPERSANT, AND COLORING COMPOSITION 大塚化学株式会社 2024-06-06 WO disclosed
WO-2024116875-A1 BLOCK COPOLYMER, DISPERSING AGENT, AND COLORED COMPOSITION 大塚化学株式会社 2024-06-06 WO disclosed
CN-117586645-A Coloring composition containing dioxazine pigment and color filter 大塚化学株式会社 2024-02-23 CN disclosed
EP-3338616-B1 OPTICAL FILM, CONNECTING MEMBER, ENDOSCOPE CAMERA DRAPE, ENDOSCOPE DEVICE, MEDICAL SYSTEM, OPTICAL FILM PRODUCTION METHOD, AND CONNECTING MEMBER PRODUCTION METHOD DEXERIALS CORP (JP) 2023-12-20 EP disclosed
US-11713294-B2 Method for producing organic tellurium compound and method for producing vinyl polymer OTSUKA CHEMICAL CO., LTD (JP) 2023-08-01 US disclosed
US-11701195-B2 Optical film, connecting member, endoscope camera drape, endoscope device, medical system, optical film production method, and connecting member production method DEXERIALS CORPORATION (JP) 2023-07-18 US disclosed
CN-113166050-B Method for producing organotellurium compound and method for producing vinyl polymer 大塚化学株式会社 2023-04-18 CN disclosed
EP-3290203-B1 ACTIVE ENERGY RAY-CURABLE RESIN COMPOSITION, ANTIFOGGING ANTIFOULING LAMINATE, ARTICLE, METHOD FOR PRODUCING SAME, AND ANTIFOULING METHOD DEXERIALS CORP (JP) 2022-08-03 EP disclosed
CN-111971116-B Dispersant composition, coloring composition and color filter 大塚化学株式会社 2022-06-28 CN disclosed
US-20030148073-A1 Porous organic particles for ink recording element use EASTMAN KODAK COMPANY 2003-08-07 US disclosed
EP-1321302-A2 Porous organic particles for ink recording element use EASTMAN KODAK COMPANY (US) 2003-06-25 EP disclosed
US-6554419-B2 Loading a printer that is responsive to digital data signals with recording element of a support having an image-receiving layer made of porous polymeric particles in a polymeric binder EASTMAN KODAK COMPANY 2003-04-29 US disclosed
US-6541103-B2 Support with an image-receiving layer of porous polymers of ethylenically unsaturated and cationic group containing monomers EASTMAN KODAK COMPANY 2003-04-01 US disclosed
US-20030044581-A1 Ink jet recording element EASTMAN KODAK COMPANY 2003-03-06 US disclosed
US-20020176966-A1 Ink jet printing method EASTMAN KODAK COMPANY 2002-11-28 US disclosed
EP-1245401-A2 Ink jet recording element and printing method EASTMAN KODAK COMPANY (US) 2002-10-02 EP disclosed
US-6100312-A A CURABLE QUATERNARY AMMONIUM ADDITION COPOLYMER WITH A DISPERSED FINE-GRAIN PIGMENT; STORAGE STABILITY; COLOR FILTER USED IN A LIQUID CRYSTAL DISPLAY ELEMENT FUJI PHOTO CO., LTD. (JP) 2000-08-08 US disclosed
US-5998091-A COPOLYMER OF A MONOFUNCTIONAL MACROMONOMER HAVING A PARTICULAR POLYMERIZABLE DOUBLE BOND-CONTAINING GROUP SITUATED AT ONLY ONE END OF THE MAIN CHAIN, A QUATERNARY AMMONIUM SALT AND AN AMIDE FUJI PHOTO FILM CO., LTD. (JP) 1999-12-07 US disclosed
US-5385802-A Process for producing toner FUJI XEROX CO., LTD. (JP) 1995-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11713294-B2 Method for producing organic tellurium compound and method for producing vinyl polymer TERB1, EMG1, ME1 CHRM1 27/4885CHRM3 687/4885CHRM2 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.